NCT01096979View on ClinicalTrials.gov

An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Subcutaneous Abdominal Adiposity

Interventions

DRUG

LIPO-102

subcutaneous injection

DRUG

Placebo

Placebo

Trial Locations (2)

Unknown

Anaheim

San Diego

Sponsors

Lead Sponsor

Neothetics, Inc

All Listed Sponsors

lead

Neothetics, Inc

INDUSTRY